Jiangsu Huili Biological Technology Co., Ltd.

LANGUAGE

Professional focus, innovation, and progress

The company integrates scientific research, production creation, and sales, committed to developing the biochemical and health industries

Biosynthesis Innovation Platform

Driven by the advanced synthetic biology enzyme computing design platform, its complete R&D and technology transformation chain ensures the rapid and large-scale mass production of new technologies. More than 10 kinds of products with independent intellectual property rights and market potential have been development in fields such as pharmaceutical intermediates, functional food raw materials, and enzyme preparations.

Biosynthetic research

In-depth research on the computational design of enzyme components, with good scientific research results
……

Enzyme engineering
Computing Design Platform

Advanced enzyme engineering computing platform, R&D team with multidisciplinary background
……

Synthetic biology

System Solution

The closed-loop commercialization of pyrazine carboxylic acid was accomplished in two and a half years, quickly realizing the
……

Recommended literature of synthetic biology: peroxisome metabolic coupling is combined into fatty alcohol

Summary The efficient utilization and biotransformation of one-carbon compounds are the current research hotspots in the field of biomanufacturing. Among them, methanol can be prepared from CO2 in large quantities, so it is considered to be an environmentally friendly biomanufacturing raw material with potential. Due to the cytotoxicity of methanol and formaldehyde

2023-04-17

Expert Review Nature | Yu Hongjun/Liu Xiaotian/Zhang Min Reveals Fungal Cell Wall β- The molecular basis of 1,3-glucan synthesis and the mechanism of resistance to echinococcin antifungal drugs

Reviews | Wang Linqi (Institute of Microbiology, Chinese Academy of Sciences), Huang Yihua (Institute of Biophysics, Chinese Academy of Sciences), Ni Ming (Tongji Hospital) Xi

2023-02-25

Ten conjectures of synthetic biology in 2023

According to the "Synthetic Biology Industry Investment Report", from 2018 to 2022, China's synthetic biology primary market has completed a total of 1039 investment and financing events. This report specially invites ten industry professionals from academic institutions, industry and related social institutions to imagine and express their unique opinions from the perspectives of industry trends, breakthroughs in key technologies, and future products. From the underlying technology research to industrial applications, from our medical treatment to food, China's synthetic biology ecology is vibrant.

2023-04-17

Huili Biology completed round A financing and added synthetic biology track

Recently, a new generation of synthetic biology enzyme computing design platform - Huili Biotech announced the completion of nearly 3 million yuan of Series A financing, jointly led by Legend Capital and Boyuan Capital, followed by Qianji Capital, Yunqi Capital and Zhongwei Capital, and Taihe Capital served as financial advisors. This round of financing will be used to accelerate the construction and operation of large-scale production facilities, the R&D of new product pipelines, and the expansion of talent teams.

2022-07-04

Copyright:Jiangsu Huili Biological Technology Co., Ltd. 苏ICP备2021019911号-1